October 26-28, 2017 Paris, France Key Topics : Epidemiology, Microbial Pathogenesis, Nosocomial Infections, Infection Control, Parasitic Diseases, Fungal Diseases, Viral Infections, Bacterial diseases, Antimicrobial Agents, Disease Diagnosis and Prevention, Antimicrobials and Chemotherapy, Dynamics and consequences of antimicrobial resistance, Microbial Biochemistry, Infectious diseases, Health Science, Host Pathogen Interactions, Medical Microbiology,

February 27-28, 2017 Amsterdam, Netherlands Key Topics : Identification and characterization of Mycotoxins, Co-occurrence and Co-exposure, Disease and Mycotoxins monitoring, Detoxification/Degradation, Impact on Human Health and animal health, Toxicology, Carcinogenic myco-toxins and Epidemiology, Food contamination and control methodologies, Genetic-bio molecular controls of biosynthesis, Entrepreneur Investments Meet: Description, Mycotoxins in Agriculture and Food Safety, Mycotoxins and Phycotoxins, Applied Mycology, Chemistry of Mycotoxins, Mycotoxins Metabolites in Human and Animals, Chromatography of Mycotoxins, Mycotoxins in grain, Environmental Mycology, Mycotoxic Fungi, Food and Nutrition Toxicology, Food Borne Diseases, Fungal Allergy and Pathogenicity, Fungal Biotechnology,

September 18-19, 2017 Dublin, Ireland Key Topics : Emerging Techniques in Bacteriology, Advances of Techniques in Virology, Innovations in Veterinary Microbiology, Enumeration of Environmental Microbiology, Improvements in Agricultural Microbiology, Flora in Soil & Water Microbiology, Futuristic Innovations in Industrial & Food Microbiology, Pure Microbiology & Microbes World, Melioration in Mycology & Phycology, Nematology & Proto-Zoology, Advances in Medical Parasitology, Microbial Identification & Physiology, Breakthrough Approaches in Medical & Molecular Microbiology, Microbial Immunology & Infection Control, Current Trends in Microbiology, Vaccines & Anti-Microbials,

July 17-18, 2017 Munich, Germany Key Topics : Potential Use of Beneficial Microorganisms, Microbial Association-Microbial Interactions, Host Microbe Interactions, Probiotics-Prebiotics Research, Microbial Ecology, Microbial Diversity, Plant-Microbe Interactions, Environmental Microbiology, Microbial Diseases and Epidemiology, Agricultural Microbiology, Microbial Mechanisms of Pathogenicity, Microbes of Water Ecosystem, Industrial Use of Microbes, Soil Microbiology, Microbial Biotechnology, Biofilm Formation, Microbes in Biogeochemical Models, Beneficial Microbes in Food Technology, Forest Microbiology, Biodegradation, Bioremediation, Microbiology in Medical, Pharmaceutical and Cosmetic Industry,

Mar 27-28, 2017 Madrid, Spain Key Topics : Cell Therapy, Cellular Therapy Technologies, Cell Therapy of Cardiovascular Disorders, Cell Therapy for Cancer, Cell Culture & Bioprocessing:, Cell Science & Stem Cell Research:, Cell Line Development, Tissue Science & Regenerative Medicine, Gene Therapy, Viral gene therapy, Diabetis Gene Therapy, Vectors for Gene Therapy, Molecular Epigenetics, Genetics & Genomic Medicine, Gene Therapy Commercialization, Clinical trials in cell and gene therapy, Gene Therapy for rare & Common Diseases, Gene Editing Technology, Cell Therapy for Neurological Disorders, Ethical Issues in Cell & Gene Therapy, Regulatory & Safety Aspects of Cell & Gene Therapy, Clinical Trails on Cell & Gen Therapy, Markets & Future Prospects for Cell & Gene Therapy, Cell & Gene Therapy Products,

August 29-31, 2017 London, UK Key Topics : Neurology, Pediatric Neurology, Neurophysiology, Neurological Disorders, Neuroinfections and Neuroimmunological disorders, Central nervous system, Neuro Muscular Disorders, Neurosurgery, Neuropathology and Neuroanatomy for diagnostician, Neuroimaging and Radiology, Neuroplasticity & Neurorehabilitation, Clinical Neurology and Neuropsychiatry, Neuropharmacology, Neurogenetic and Neurometabolic disorders, Nursing Care in Neurology, Neurotherapeutics, Diagnostics and Case Studies, Spine Surgery and Spine Disorders,

Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.